ArticlePloS one2025

Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines.

Mohamed El-Tanani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.